The FDA has cleared over 150 artificial intelligence- or machine learning-enabled medical devices since the beginning of August.

Radiology is going though a period of disruption with a growing radiologist shortage, decreasing reimbursements and increasing numbers of exams, making workflow efficiency a critical concern.

Dedicated teleradiology services could expand quality healthcare in regions where access and staffing shortages hinder patient care the most. 

Blue Earth will be sharing anonymized clinical data from its Phase 3 Lighthouse trial involving the use of PET imaging agent Posluma.

The model incorporates specific data from MRI exams with patient risk factors to predict whether a person is likely to develop clinically significant prostate cancer.

Contextualized reports differ from structured reports in that they focus on specific clinical indications, rather than a basic standardized checklist of anatomical regions that does not always address a particular concern.

The model was developed and validated specifically for liver, spleen and pancreas segmentation, and outperformed a publicly available segmentation model already in use.

Although these tools have proven themselves valuable in numerous settings, they must be used with caution, especially by patients and nonradiologist providers who may be seeking clarification on imaging reports.